Microscale flow chemistry uses 'switchable solvents' to improve extraction
New green technology enables accelerated screening and retrieval of "switchable" solvents for chemical and pharmaceutical applications. Utilizing microfluidic strategies, researchers developed an in situ approach to study gas-liquid processes in a time- and material-efficient manner. The work was published online in ACS Sustainable Chemistry and Engineering on February 6. Read More
Audentes plans gene therapy facility in NC
Audentes Therapeutics has announced that it plans to invest $109 million to build a new 135,00-sq-ft gene therapy manufacturing facility in Sanford, NC, that is expected to be operational by 2021. Read More
MilliporeSigma to make Elypta liquid biopsy kits
MilliporeSigma has signed an agreement with Swedish molecular diagnostics company Elypta to be the contract manufacturer for Elypta's clinical diagnostic liquid biopsy kits. Read More
Thermo Fisher, NanoPin partner on infectious disease tech
Thermo Fisher Scientific will partner with infectious diseases diagnostic company NanoPin Technologies to develop workflows for liquid chromatography-mass spectrometry. Read More
Bioprocessing Summit Europe to be held March 24-26
The Bioprocessing Summit Europe will return to Barcelona, Spain, this year to address the growing global market for gene therapy and biopharmaceutical manufacturing. The summit will take place from March 24 to 26. Read More
Catalent completes acquisition of MaSTherCell
Catalent announced on February 11 that it has completed its acquisition of MaSTherCell Global, improving Catalent's position in the field of advanced biotherapeutics. Read More
Bosc named president of Women in Bio
Jessica Bosc, director of business development and licensing at Selexis, has been named president of Women in Bio, following a one-year term as president-elect. Read More
MilliporeSigma unveils BrightLab for research scientists
MilliporeSigma has introduced BrightLab, a cloud-based inventory management and instrument connectivity platform for research scientists. Read More
Trump's 2021 budget calls for 8% NIH cut
U.S. President Donald Trump on February 10 released a proposed budget for 2021 that includes an 8% cut in funding to the U.S. National Institutes of Health (NIH), proposing a 2021 budget of $38 billion, compared with the $41.4 billion for 2020. Read More
ReForm Biologics, MilliporeSigma ink license agreement
ReForm Biologics and MilliporeSigma have signed a licensing agreement to develop and market excipients used for biotherapeutic applications. The agreement dictates that the two firms will research and develop ReForm Biologics' excipients for pharmaceutical use. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter